Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

Seoulin Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 28, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	58,169	61,462	78,767	97,546	174,747	107,487
Market Cap Growth	-8.32%	-21.97%	-19.25%	-44.18%	62.58%	56.83%
Enterprise Value	38,413	39,202	46,863	48,995	136,075	93,693
Last Close Price	6590.00	6848.34	8536.47	10443.86	18486.57	11307.17
PE Ratio	29.61	21.09	-	9.60	11.21	21.97
PS Ratio	0.76	0.82	0.88	0.93	2.17	1.65
PB Ratio	0.67	0.71	0.92	1.10	2.28	1.75
P/TBV Ratio	0.69	0.74	0.96	1.17	2.36	1.82
P/FCF Ratio	98.85	-	-	-	21.89	32.74
P/OCF Ratio	80.52	-	84.64	-	19.60	29.17
EV/Sales Ratio	0.50	0.52	0.52	0.47	1.69	1.44
EV/EBITDA Ratio	24.26	16.92	12.39	4.80	14.51	14.52
EV/EBIT Ratio	105.53	41.15	18.79	5.33	18.26	20.96
EV/FCF Ratio	65.28	-	-	-	17.04	28.54
Debt / Equity Ratio	0.11	0.04	0.08	0.20	0.21	0.01
Debt / EBITDA Ratio	5.92	1.59	1.78	1.74	1.68	0.12
Debt / FCF Ratio	15.82	-	-	-	1.97	0.23
Asset Turnover	0.73	0.70	0.72	0.77	0.75	0.82
Inventory Turnover	2.59	2.35	3.57	5.15	4.63	4.09
Quick Ratio	1.46	2.30	1.77	1.35	1.44	2.13
Current Ratio	2.57	4.39	2.60	1.88	1.77	3.06
Return on Equity (ROE)	3.12%	3.65%	-2.67%	12.78%	23.03%	7.83%
Return on Assets (ROA)	0.21%	0.55%	1.25%	4.23%	4.34%	3.52%
Return on Invested Capital (ROIC)	0.53%	1.36%	4.63%	20.31%	19.66%	9.08%
Return on Capital Employed (ROCE)	0.40%	1.10%	2.90%	10.30%	9.70%	6.90%
Earnings Yield	3.65%	4.74%	-0.15%	10.41%	8.92%	4.55%
FCF Yield	1.01%	-7.58%	-0.02%	-4.94%	4.57%	3.05%
Dividend Yield	1.42%	1.39%	-	-	-	-
Payout Ratio	39.78%	28.70%	-	7.86%	4.93%	14.74%
Buyback Yield / Dilution	-4.78%	0.50%	19.46%	-23.72%	0.07%	1.26%
Total Shareholder Return	-3.34%	1.89%	19.46%	-23.72%	0.07%	1.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.